Eva van den Berg-de Ruiter
Eva van den Berg-de Ruiter
Dept. Genetics (MGE), UMCG Groningen, Groningen, the Netherlands
Verified email at umcg.nl - Homepage
TitleCited byYear
The Heidelberg classification of renal cell tumours
G Kovacs, M Akhtar, BJ Beckwith, P Bugert, CS Cooper, B Delahunt, ...
The Journal of Pathology: A Journal of the Pathological Society of Great …, 1997
14001997
SOFT TISSUE LEIOMYOSARCOMAS AND MALIGNANT GASTROINTESTINAL STROMAL TUMORS: DIFFERENCES IN CLINICAL OUTCOME AND IN EXPRESSION OF MULTIDRUG RESISTANCE PROTEINS
BEC Plaat, H Hollema, WM Molenaar, GHT Broers, J Pijpe, MF Mastik, ...
SOFT TISSUE SARCOMAS: HISTOPATHOLOGY AND CYTOGENETICS IN RELATION TO …, 2000
3022000
Cytogenetics of childhood acute myeloid leukemia: United Kingdom Medical Research Council Treatment trials AML 10 and 12
CJ Harrison, RK Hills, AV Moorman, DJ Grimwade, I Hann, DKH Webb, ...
Journal of clinical oncology 28 (16), 2674-2681, 2010
2392010
Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997–2004)
AJ Veerman, WA Kamps, H van den Berg, E van den Berg, ...
The lancet oncology 10 (10), 957-966, 2009
1932009
Histone methyltransferase gene SETD2 is a novel tumor suppressor gene in clear cell renal cell carcinoma
G Duns, E van den Berg, I van Duivenbode, J Osinga, H Hollema, ...
Cancer research 70 (11), 4287-4291, 2010
1902010
Upregulation of the transcription factor TFEB in t (6; 11)(p21; q13)-positive renal cell carcinomas due to promoter substitution
RP Kuiper, M Schepens, J Thijssen, M van Asseldonk, E van den Berg, ...
Human molecular genetics 12 (14), 1661-1669, 2003
1772003
Clinical, molecular, and prognostic significance of WHO type inv (3)(q21q26. 2)/t (3; 3)(q21; q26. 2) and various other 3q abnormalities in acute myeloid leukemia
S Lugthart, S Gröschel, HB Beverloo, S Kayser, PJM Valk, ...
Journal of clinical oncology 28 (24), 3890-3898, 2010
1762010
Cytogenetic analysis of epithelial renal‐cell tumors: relationship with a new histopathological classification
E Van den Berg, AH Van der Hout, JW Oosterhuis, S Störkel, T Dijkhuizen, ...
International journal of cancer 55 (2), 223-227, 1993
1741993
The value of the MDR1 reversal agent PSC-833 in addition to daunorubicin and cytarabine in the treatment of elderly patients with previously untreated acute myeloid leukemia …
B van der Holt, B Löwenberg, AK Burnett, WU Knauf, J Shepherd, ...
Blood 106 (8), 2646-2654, 2005
1652005
BFM-oriented treatment for children with acute lymphoblastic leukemia without cranial irradiation and treatment reduction for standard risk patients: results of DCLSG protocol …
WA Kamps, JPM Bökkerink, F Hakvoort-Cammel, AJP Veerman, ...
Leukemia 16 (6), 1099, 2002
1502002
Follicular lymphoma grade 3B includes 3 cytogenetically defined subgroups with primary t (14; 18), 3q27, or other translocations: t (14; 18) and 3q27 are mutually exclusive
AG Bosga-Bouwer, GW van Imhoff, R Boonstra, A van der Veen, ...
Blood 101 (3), 1149-1154, 2003
1492003
Morphological classification of renal cancer
S Störkel, E Van Den Berg
World journal of urology 13 (3), 153-158, 1995
1251995
Regulation of plasminogen activator inhibitor-1 mRNA in human endothelial cells
EA Van den Berg, ED Sprengers, M Jaye, W Burgess, T Maciag, ...
Thrombosis and haemostasis 60 (01), 063-067, 1988
1121988
Intensive treatment of children with acute lymphoblastic leukemia according to ALL-BFM-86 without cranial radiotherapy: results of Dutch Childhood Leukemia Study Group Protocol …
WA Kamps, JPM Bökkerink, K Hählen, J Hermans, H Riehm, H Gadner, ...
Blood 94 (4), 1226-1236, 1999
1101999
Targeted sequencing by proximity ligation for comprehensive variant detection and local haplotyping
PJP De Vree, E De Wit, M Yilmaz, M Van De Heijning, P Klous, ...
Nature biotechnology 32 (10), 1019, 2014
1032014
Germline and somatic NF1 mutations in sporadic and NF1‐associated malignant peripheral nerve sheath tumours
I Bottillo, T Ahlquist, H Brekke, SA Danielsen, E van den Berg, F Mertens, ...
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2009
1022009
Activity and expression of the multidrug resistance proteins MRP1 and MRP2 in acute myeloid leukemia cells, tumor cell lines, and normal hematopoietic CD34+ peripheral blood cells.
DM van der Kolk, EG De Vries, JA Koning, E van den Berg, M Müller, ...
Clinical Cancer Research 4 (7), 1727-1736, 1998
971998
Activity and expression of the multidrug resistance proteins P-glycoprotein, MRP1, MRP2, MRP3 and MRP5 in de novo and relapsed acute myeloid leukemia
DM Van der Kolk, EGE de Vries, L Noordhoek, E Van Den Berg, ...
Leukemia 15 (10), 1544, 2001
872001
An alternative route for multistep tumorigenesis in a novel case of hereditary renal cell cancer and at (2; 3)(q35; q21) chromosome translocation
D Bodmer, MJ Eleveld, MJL Ligtenberg, MAJ Weterman, BAP Janssen, ...
The American Journal of Human Genetics 62 (6), 1475-1483, 1998
851998
Chromosomal changes in renal oncocytomas Evidence that t (5; 11)(q35; q13) may characterize a second subgroup of oncocytomas
E Van den Berg, T Dijkhuizen, S Störkel, GB de la Riviere, A Dam, ...
Cancer genetics and cytogenetics 79 (2), 164-168, 1995
791995
The system can't perform the operation now. Try again later.
Articles 1–20